Hikma Pharmaceuticals PLC
HKMPY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6 | $6 | $5 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $1 | $1 | $1 |
| Enterprise Value | $7 | $7 | $6 | $6 |
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | 6.4% | -0.7% | 9.2% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 43.7% | 39.1% | 48.2% | 43.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28.7% | 19.8% | 27.2% | 14.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 14.4% | 8.5% | 14.4% | 4.1% |
| EPS Diluted | 2.14 | 1.18 | 2.02 | 0.52 |
| % Growth | 81.4% | -41.6% | 288.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |